Zobrazeno 1 - 10
of 303
pro vyhledávání: '"Bernhard, Wörmann"'
Autor:
Elaine Julian, Oriol Solà-Morales, Maria João Garcia, Francine Brinkhuis, Mira Pavlovic, Carlos Martín-Saborido, Robin Doeswijk, Rosa Giuliani, Anne Willemsen, Wim Goettsch, Bernhard Wörmann, Urania Dafni, Heiner C. Bucher, Begoña Pérez-Valderrama, Renato Bernardini, Fabrizio Gianfrate, Carin A. Uyl-de Groot, Jörg Ruof
Publikováno v:
Journal of Market Access & Health Policy, Vol 12, Iss 3, Pp 128-143 (2024)
Background: This work aimed to determine the role and action points for the involvement of medical societies in the European Health Technology Assessment (EU HTA) Methods: An online pre-convention survey was developed addressing four areas related to
Externí odkaz:
https://doaj.org/article/f7baa0ed8a53416196beab87cb2d5619
Autor:
Susanne Thieme, Alexander Graf, Stefan Krebs, Helmut Blum, Maria Solovey, Frank Ziemann, Jonathan Christ, Maja Rothenberg-Thurley, Annika Dufour, Stephanie Schneider, Maria Cristina Sauerland, Dennis Görlich, Utz Krug, Wolfgang E. Berdel, Bernhard Wörmann, Wolfgang Hiddemann, Jan Braess, Karsten Spiekermann, Klaus Metzeler, Ulrich Mannsmann, Tobias Herold
Publikováno v:
HemaSphere, Vol 7, p e03586b2 (2023)
Externí odkaz:
https://doaj.org/article/72e658958a7b40f982f779afcdea8308
Autor:
Jan Schildmann, Marc Cinci, Leonie Kupsch, Michael Oldenburg, Bernhard Wörmann, Stephan Nadolny, Eva Winkler
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1813-1820 (2023)
Abstract Background Cancer patients form a notable proportion of requestors for physician‐assisted suicide (PAS). This manuscript provides data on German oncologists' views concerning due criteria for the assessment of requests for PAS and quality
Externí odkaz:
https://doaj.org/article/bc67ace0d1b142b8898bb8cf90ea8faa
Autor:
Farhad Ravandi, Robert J. Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sasha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E. Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B. Johnston, Jeffrey Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A. Parikh, Jae H. Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A. Rogers, Alan Saven, John F. Seymour, Tamar Tadmor, Martin S. Tallman, Constantine S. Tam, Philip A. Thompson, Xavier Troussard, Clive S. Zent, Thorsten Zenz, Pier Luigi Zinzani, Bernhard Wörmann, Kanti Rai, Michael Grever
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 12, Pp 1-7 (2022)
Abstract A significant body of literature has been generated related to the detection of measurable residual disease (MRD) at the time of achieving complete remission (CR) in patients with hairy cell leukemia (HCL). However, due to the indolent natur
Externí odkaz:
https://doaj.org/article/b522c851a9074f98bd78424982d9e633
Autor:
Desiree Kunadt, Sebastian Stasik, Klaus H. Metzeler, Christoph Röllig, Christoph Schliemann, Philipp A. Greif, Karsten Spiekermann, Maja Rothenberg-Thurley, Utz Krug, Jan Braess, Alwin Krämer, Andreas Hochhaus, Sebastian Scholl, Inken Hilgendorf, Tim H. Brümmendorf, Edgar Jost, Björn Steffen, Gesine Bug, Hermann Einsele, Dennis Görlich, Cristina Sauerland, Kerstin Schäfer-Eckart, Stefan W. Krause, Mathias Hänel, Maher Hanoun, Martin Kaufmann, Bernhard Wörmann, Michael Kramer, Katja Sockel, Katharina Egger-Heidrich, Tobias Herold, Gerhard Ehninger, Andreas Burchert, Uwe Platzbecker, Wolfgang E. Berdel, Carsten Müller-Tidow, Wolfgang Hiddemann, Hubert Serve, Matthias Stelljes, Claudia D. Baldus, Andreas Neubauer, Johannes Schetelig, Christian Thiede, Martin Bornhäuser, Jan M. Middeke, Friedrich Stölzel, the A. M. L. Cooperative Group (AMLCG), Study Alliance Leukemia (SAL)
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-15 (2022)
Abstract Background The role of allogeneic hematopoietic cell transplantation (alloHCT) in acute myeloid leukemia (AML) with mutated IDH1/2 has not been defined. Therefore, we analyzed a large cohort of 3234 AML patients in first complete remission (
Externí odkaz:
https://doaj.org/article/1665eacc6b1a46028a7f2723eae46d4a
Autor:
Bernhard Wörmann
Publikováno v:
best practice onkologie. 18:190-193
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0688a7a53479c1c0e39565078952fcf3
https://doi.org/10.1007/s11654-023-00489-6
https://doi.org/10.1007/s11654-023-00489-6
Autor:
Bernhard Wörmann
Publikováno v:
best practice onkologie. 18:138-141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ad916c892f9f1abc971ab06f9a706dc
https://doi.org/10.1007/s11654-023-00483-y
https://doi.org/10.1007/s11654-023-00483-y
Autor:
Nicola Giesen, Elena Busch, Enrico Schalk, Gernot Beutel, Maria M. Rüthrich, Marcus Hentrich, Bernd Hertenstein, Hans H. Hirsch, Meinolf Karthaus, Yascha Khodamoradi, Philipp Koehler, William Krüger, Michael Koldehoff, Robert Krause, Sibylle C. Mellinghoff, Olaf Penack, Michael Sandherr, Ruth Seggewiss-Bernhardt, Karsten Spiekermann, Rosanne Sprute, Jannik Stemler, Florian Weissinger, Bernhard Wörmann, Hans-Heinrich Wolf, Oliver A. Cornely, Christina T. Rieger, Marie von Lilienfeld-Toal
Publikováno v:
European Journal of Cancer. 181:102-118
The novel coronavirus SARS-CoV-2 and the associated infectious disease COVID-19 pose a significant challenge to healthcare systems worldwide. Patients with cancer have been identified as a high-risk population for severe infections, rendering prophyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6374171501f45e188cd2cd8a89285a0a
https://doi.org/10.1016/j.ejca.2022.11.030
https://doi.org/10.1016/j.ejca.2022.11.030
Autor:
Bernhard Wörmann
Publikováno v:
best practice onkologie. 18:78-81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::553db716bdba8d02cda4820916572d09
https://doi.org/10.1007/s11654-023-00466-z
https://doi.org/10.1007/s11654-023-00466-z
Autor:
Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke, Georg Maschmeyer, Haifa Kathrin Al-Ali, Sebastian Schwind, Madlen Jentzsch, Michael Cross, Christoph Kahl, Hans-Heinrich Wolf, Herbert Sayer, Antje Schulze, Peter Dreger, Ute Hegenbart, Alwin Krämer, Christian Junghanss, Lars-Olof Mügge, Detlev Hähling, Carsten Hirt, Christian Späth, Norma Peter, Bernhard Opitz, Axel Florschütz, Kolja Reifenrath, Niklas Zojer, Sebastian Scholl, Wolfram Pönisch, Simone Heyn, Vladan Vucinic, Andreas Hochhaus, Carlo Aul, Aristoteles Giagounidis, Leopold Balleisen, Bernd Oldenkott, Peter Staib, Michael Kiehl, Wolfgang Schütte, Ralph Naumann, Hartmut Eimermacher, Bernd Dörken, Cristina Sauerland, Eva Lengfelder, Wolfgang Hiddemann, Bernhard Wörmann, Carsten Müller-Tidow, Hubert Serve, Christoph Schliemann, Rüdiger Hehlmann, Wolfgang E. Berdel, Markus Pfirrmann, Utz Krug, Verena S. Hoffmann
Publikováno v:
Annals of Hematology. 102:547-561
A randomized inter-group trial comparing more intensive treatment strategies to a common standard arm 3 + 7 (CSA) was conducted in patients with non-M3 AML. Untreated patients ≥ 60 years were allocated to the CSA (n = 132) or to the study group arm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d797fe8fd930f495cbd3f8b52e46404
https://doi.org/10.1007/s00277-023-05087-8
https://doi.org/10.1007/s00277-023-05087-8